These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 20596634)

  • 1. Expression profile of RhoGDI2 in lung cancers and role of RhoGDI2 in lung cancer metastasis.
    Niu H; Li H; Xu C; He P
    Oncol Rep; 2010 Aug; 24(2):465-71. PubMed ID: 20596634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuromedin U is regulated by the metastasis suppressor RhoGDI2 and is a novel promoter of tumor formation, lung metastasis and cancer cachexia.
    Wu Y; McRoberts K; Berr SS; Frierson HF; Conaway M; Theodorescu D
    Oncogene; 2007 Feb; 26(5):765-73. PubMed ID: 16878152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Invasion and metastasis models for studying RhoGDI2 in bladder cancer.
    Nitz MD; Harding MA; Theodorescu D
    Methods Enzymol; 2008; 439():219-33. PubMed ID: 18374168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endothelin axis is a target of the lung metastasis suppressor gene RhoGDI2.
    Titus B; Frierson HF; Conaway M; Ching K; Guise T; Chirgwin J; Hampton G; Theodorescu D
    Cancer Res; 2005 Aug; 65(16):7320-7. PubMed ID: 16103083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rho GDP dissociation inhibitor 2 suppresses metastasis via unconventional regulation of RhoGTPases.
    Moissoglu K; McRoberts KS; Meier JA; Theodorescu D; Schwartz MA
    Cancer Res; 2009 Apr; 69(7):2838-44. PubMed ID: 19276387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical significance of Rho GDP dissociation inhibitor 2 in colorectal carcinoma.
    Fujita A; Shida A; Fujioka S; Kurihara H; Okamoto T; Yanaga K
    Int J Clin Oncol; 2012 Apr; 17(2):137-42. PubMed ID: 21698524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Src phosphorylation of RhoGDI2 regulates its metastasis suppressor function.
    Wu Y; Moissoglu K; Wang H; Wang X; Frierson HF; Schwartz MA; Theodorescu D
    Proc Natl Acad Sci U S A; 2009 Apr; 106(14):5807-12. PubMed ID: 19321744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RhoGDI2 as a therapeutic target in cancer.
    Cho HJ; Baek KE; Yoo J
    Expert Opin Ther Targets; 2010 Jan; 14(1):67-75. PubMed ID: 20001211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RhoGDI2 expression is associated with tumor growth and malignant progression of gastric cancer.
    Cho HJ; Baek KE; Park SM; Kim IK; Choi YL; Cho HJ; Nam IK; Hwang EM; Park JY; Han JY; Kang SS; Kim DC; Lee WS; Lee MN; Oh GT; Kim JW; Lee CW; Yoo J
    Clin Cancer Res; 2009 Apr; 15(8):2612-9. PubMed ID: 19351766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RNA interference-mediated knockdown of RhoGDI2 induces the migration and invasion of human lung cancer A549 cells via activating the PI3K/Akt pathway.
    Niu H; Wu B; Peng Y; Jiang H; Zhang Y; Wang J; Zhang Y; He P
    Tumour Biol; 2015 Jan; 36(1):409-19. PubMed ID: 25266803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relationship of BRMS1 and RhoGDI2 gene expression to metastatic potential in lineage related human bladder cancer cell lines.
    Seraj MJ; Harding MA; Gildea JJ; Welch DR; Theodorescu D
    Clin Exp Metastasis; 2000; 18(6):519-25. PubMed ID: 11592309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathways of metastasis suppression in bladder cancer.
    Said N; Theodorescu D
    Cancer Metastasis Rev; 2009 Dec; 28(3-4):327-33. PubMed ID: 20013033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biphasic expression of RhoGDI2 in the progression of breast cancer and its negative relation with lymph node metastasis.
    Hu LD; Zou HF; Zhan SX; Cao KM
    Oncol Rep; 2007 Jun; 17(6):1383-9. PubMed ID: 17487395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RhoGDI2 is an invasion and metastasis suppressor gene in human cancer.
    Gildea JJ; Seraj MJ; Oxford G; Harding MA; Hampton GM; Moskaluk CA; Frierson HF; Conaway MR; Theodorescu D
    Cancer Res; 2002 Nov; 62(22):6418-23. PubMed ID: 12438227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms of RhoGDI2 mediated lung cancer epithelial-mesenchymal transition suppression.
    Niu H; Wu B; Jiang H; Li H; Zhang Y; Peng Y; He P
    Cell Physiol Biochem; 2014; 34(6):2007-16. PubMed ID: 25562149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RhoGDI2: a new metastasis suppressor gene: discovery and clinical translation.
    Harding MA; Theodorescu D
    Urol Oncol; 2007; 25(5):401-6. PubMed ID: 17826660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RhoC Is an Unexpected Target of RhoGDI2 in Prevention of Lung Colonization of Bladder Cancer.
    Griner EM; Dancik GM; Costello JC; Owens C; Guin S; Edwards MG; Brautigan DL; Theodorescu D
    Mol Cancer Res; 2015 Mar; 13(3):483-92. PubMed ID: 25516960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Depletion of RhoGDI2 expression inhibits the ability of invasion and migration in pancreatic carcinoma.
    Yi B; Hu Y; Qin G; Gu W; Zhu X; He S; Zhou J; Li D
    Int J Mol Med; 2014 Jul; 34(1):205-12. PubMed ID: 24788627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RhoGDI2 confers gastric cancer cells resistance against cisplatin-induced apoptosis by upregulation of Bcl-2 expression.
    Cho HJ; Baek KE; Park SM; Kim IK; Nam IK; Choi YL; Park SH; Im MJ; Choi J; Ryu J; Kim JW; Lee CW; Kang SS; Yoo J
    Cancer Lett; 2011 Dec; 311(1):48-56. PubMed ID: 21752536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of RhoGDI2 in the resistance of colon cancer cells to 5-fluorouracil.
    Zheng Z; Li J; He X; Chen X; Yu B; Ji J; Zhang J; Wang T; Gu Q; Zhu Z; Liu B
    Hepatogastroenterology; 2010; 57(102-103):1106-12. PubMed ID: 21410040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.